Could a Non-Stimulant drug ease ADHD-Like symptoms in autism?
NCT ID NCT00498173
Summary
This study tested whether the medication atomoxetine (Strattera®) could safely reduce symptoms of inattention, hyperactivity, and impulsivity in children and teenagers with autism. Sixty participants with autism and significant ADHD-like symptoms were randomly assigned to receive either the drug or a placebo for 8 weeks. The goal was to see if this non-stimulant medication, already used for ADHD, could help manage these challenging symptoms in autistic individuals.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Christian Sarkine Autism Treatment Center at Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
-
Lurie Center - MassGeneral Hospital
Lexington, Massachusetts, 02421, United States
Conditions
Explore the condition pages connected to this study.